Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team
No Result
View All Result
Silicon Canals
No Result
View All Result

Using AI to cure ailments: UK-based BenevolentAI collaborates with AstraZeneca to hasten drug discovery

Editorial team by Editorial team
May 2, 2019
in Startups, Health & Medtech, News, Software & SaaS
0
Using AI to cure ailments: UK-based BenevolentAI collaborates with AstraZeneca to hasten drug discovery
40
SHARES
LinkedInTwitterWhatsAppFacebook

Artificial Intelligence (AI) is being used for a myriad of applications and healthcare is one such prominent field where it’s applied. While there are numerous companies that employ AI to solve varying problems, the rapidly growing UK-based startup BenevolentAI is one step ahead of the lot.

The company was founded in 2013 with the aim of digging deep into data to find insights and solutions, and to apply them to “to transform the way medicines are discovered, developed, tested and brought to market.”

BenevolentAI has now made a long-term collaboration with AstraZeneca, a US based global pharmaceutical company. The two organisations will employ machine learning and AI for discovery and development of potential new drugs, for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF). Here’s how this new partnership aims to accelerate drug discovery and development.

Amalgamating AI with human experience

With this partnership, scientists from BenevolentAI and AstraZeneca will work together. They will use BenevolentAI target identification platform and biomedical knowledge graph and combine it with AstraZeneca’s genomics, chemistry and clinical data. This will enable the machine learning system to analyse data and find insights to understand connections between facts, which were not unknown before.

Additionally, AI-based reasoning is employed to extrapolate previously undiscovered connections. The companies will then together analyse and interpret the results to “understand the underlying mechanisms of these complex diseases and more quickly identify new potential drug targets.”

Joanna Shields, CEO of BenevolentAI, says,“Millions of people today suffer from diseases that have no effective treatment. The future of drug discovery and development lies in bridging the gap between AI, data, and biology. We are thrilled to be joining forces with AstraZeneca to develop new insights and identify promising new treatments for chronic kidney disease and idiopathic pulmonary fibrosis.”

CKD and IPF are complicated diseases in which the underlying disease biology is said to be poorly understood. Therefore, this disease complexity is said to require the interrogation of vast, rich datasets. This partnership thus will help discover more about the diseases and hopefully, improve the chances of developing treatments for them.

Stay tuned to Silicon Canals for more updates in the tech startup world.

Scaling up in Europe: 5 do’s and don’ts of doing business in the Netherlands

close

Want to stay on top of the latest rounds, coolest tech and hottest startups?

Subscribe to our free, daily news blast and stay up-to-date!

Check your inbox or spam folder to confirm your subscription.

 - Partner content -
Future Hamburg Award 2021
Future Hamburg Award 2021
Call for startups with innovative solutions for the future cities from all over the globe.
Call for startups with innovative solutions for the future cities from all over the globe. Show Less
Read more
Tags: healthtechstart-up
Share3Tweet10SendShare16

Featured events

Current Month

april

No Events

Partner content | Work with us

Amsterdam-based Lumicks raises €77.6M to provide instruments to reveal unique molecular, cellular interactions

Calling all European deep-tech scaleups: EIT Digital Challenge 2021 registration is now open

Amsterdam-based SaaS startup SwipeGuide raises €5M for international expansion; aims to double its staff in 2021

Innovation against climate change: what Blue Tulip Awards’ experts on Climate & Energy are looking for

Blue Tulip Awards’ experts of Finance & Prosperity: why COVID, regulations and digitisation boost innovation

Silicon Canals Jobs


Breaking news from Amsterdam | Partner

Amsterdam’s test automation startup SEGRON raises funding; looks to increase workforce by 30% by 2021-end

After tripling its revenue in 2020, Amsterdam-based fashion e-commerce startup Otrium raises €102.3M

Amsterdam’s IoT spacetech startup Hiber raises €26M to expand the world’s first global IoT satellite network

Amsterdam-based MessageBird acquires 24sessions to add video to its omnichannel offering; also acquires Hull

  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy policy
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2020 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdam
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team

Silicon Canals 2014-2020 | Website: Bright Idiots

X

This website uses cookies to ensure the best possible experience. We may share this information with our advertising and analytics partners. By clicking 'Accept', you agree to our use of cookies and similar technologies. More info